Skip to content
MedsAcross

Medicine

Mometasone furoate 0.1% cream

Available on requestPrescription onlyUS FDAGeneric name

Mometasone furoate 0.1% cream is a generic prescription medicine for topical use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).

Key facts

Active ingredient (INN)
Mometasone furoate
Brand
Sold under the generic name
Strength
0.1%
Dosage form
Cream
Route
Topical
Packs
1 tube, 15 g and 13 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaBryant Ranch PrepackCosette PharmaceuticalsPadagis Israel PharmaceuticalsPreferred PharmaceuticalsProficient RxA-S Medication Solutions
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R01AD09 Mometasone furoate
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 December 2004
Identifiers
RxCUI 311753DailyMed set ID ad47cceb-e471-48d6-85d6-e4a3f10e2ac6, 88f5622d-64da-42b7-8aa9-62a5da5ebfbb, 2bf06b19-4ed7-41a3-b6fc-29713c41965c +9NDC 68788-4075, 71335-2873, 63187-288 +9Application ANDA077447, ANDA076679, ANDA078541

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 tube in 1 carton / 15 g in 1 tube51672-1315-1Sun Pharmaceutical IndustriesIndia21 December 2004
1 tube in 1 carton / 45 g in 1 tube51672-1315-6Sun Pharmaceutical IndustriesIndia21 December 2004
1 tube in 1 carton / 15 g in 1 tube0713-0634-15Cosette Pharmaceuticals23 August 2006
1 tube in 1 carton / 45 g in 1 tube0713-0634-37Cosette Pharmaceuticals23 August 2006
1 tube in 1 carton / 15 g in 1 tube45802-257-35Padagis Israel Pharmaceuticals5 April 2024
1 tube in 1 carton / 45 g in 1 tube45802-257-42Padagis Israel Pharmaceuticals5 April 2024
1 tube in 1 carton / 15 g in 1 tube63629-8681-1Bryant Ranch Prepack5 April 2024
1 tube in 1 carton / 45 g in 1 tube63629-8682-1Bryant Ranch Prepack21 July 2021
1 tube in 1 carton / 15 g in 1 tube71335-2873-1Bryant Ranch Prepack24 October 2025
1 tube in 1 carton / 15 g in 1 tube72162-1404-2Bryant Ranch Prepack5 April 2024
1 tube in 1 carton / 45 g in 1 tube72162-1404-4Bryant Ranch Prepack5 April 2024
1 tube in 1 carton / 45 g in 1 tube68788-4075-4Preferred Pharmaceuticals27 January 2026
1 tube in 1 carton / 45 g in 1 tube68788-8548-4Preferred Pharmaceuticals14 November 2023
15 g in 1 tube63187-288-15Proficient Rx1 January 2019
15 g in 1 tube63187-432-15Proficient Rx1 January 2019
1 tube in 1 carton / 45 g in 1 tube50090-2991-0A-S Medication Solutions28 April 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 April 1987Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Mometasone furoate

Clinical summary

Mometasone furoate is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older, among other approved uses. MedsAcross supplies Mometasone furoate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Mometasone furoate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Mometasone furoate 0.1% cream for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.